ArticleThe Journal of clinical endocrinology and metabolism2025

Correction to: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer".

No numbers read from the abstract.

Not cited yet